Skip to content

Dose-dependent Effects of Blueberry Polyphenols on Endothelial Function in Healthy Individuals

Dose-dependent Effects of Blueberry Polyphenols on Endothelial Function in Healthy Individuals

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01829542
Acronym
BB2
Enrollment
11
Registered
2013-04-11
Start date
2012-05-31
Completion date
2012-10-31
Last updated
2013-04-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Endothelial Function

Keywords

flow-mediated dilation, blueberry polyphenols, dose-dependency

Brief summary

The purpose of this study is to assess the impact of acute blueberry polyphenol intake on endothelial function of healthy volunteers. Specifically, the investigators plan to perform a randomised, double blind, cross-over human intervention trial using a blueberry drink to investigate the dose-dependent effects of blueberry polyphenols on blood vessel function using Flow mediated dilation (FMD) to measure endothelial function. The study will not only measure the acute effects of flavonoid ingestion on vascular reactivity but will also assess plasma polyphenol metabolite levels.

Interventions

DIETARY_SUPPLEMENTFreeze-dried blueberry powder dissolved in water

Wild blueberry freeze-dried powder dissolved in water

DIETARY_SUPPLEMENTControl

Macro- and micro-nutrient matched control in water

Sponsors

Alpro Foundation
CollaboratorOTHER
University of Reading
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
BASIC_SCIENCE
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
MALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Male * 18-40 years * Healthy * signed consent form

Exclusion criteria

* Blood pressure \> 140/90 mmHg * Had suffered a myocardial infarction or stroke * Suffers from any blood-clotting disorder * Suffers from any metabolic disorders (e.g. diabetes or any other endocrine or liver diseases) * Any dietary restrictions or on a weight reducing diet * Allergies or intolerances to any foods * Smoker * Heavy drinker (\>21 units per week) * On any lipid-modifying medication * On any blood pressure lowering medication * On any medication affecting blood clotting * Taking high dose fish oil supplements (greater then 1 g EPA and DHA per day) or high doses of antioxidant vitamins (greater then 800 μg vitamin A, 60 mg vitamin C, 10 mg vitamin E or 400 μg beta carotene) * Taking probiotics, prebiotics, synbiotics, antibiotics or anti-inflammatory or blood lowering medication within a 2-month period prior to the study * Planning on altering consumption of vitamin supplements/fish oil capsules during the course of the study * Undertakes strenuous exercise \> 4 times per week for \> 1 hour per session * Haemoglobin levels below reference range provided by the Royal Berkshire Hospital

Design outcomes

Primary

MeasureTime frame
Flow-mediated dilation0-1 hour after consumption

Secondary

MeasureTime frame
plasma blueberry polyphenol metabolites0-1 h after consumption

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 22, 2026